Article · Journal · 2023

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

PLoS neglected tropical diseases

Citations: 11from other works
Field-weighted impact: 1.791.00 is the world average for its field and year
Among its field: 84th percentileby citations, against works of its field and year
Authors: 17from 7 institutions

Authors

17 authors across 7 institutions in 4 countries